SM8’s Clever Buoy shark mitigation system endorsed for Southern California roll-out

Published 26-SEP-2017 12:10 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Australian marine technology group, Shark Mitigation Systems (ASX:SM8), yesterday announced some encouraging developments relating to the roll-out of its Clever Buoy system in Orange County, Southern California.

SM8 has welcomed the support of United States federal congressman, Dana Rohrabacher, for a pilot project involving the company’s Clever Buoy technology.

SM8, which is focused on expanding its Clever Buoy system in the US market, has been working with Orange County officials in recent months on an integrated shark management plan, including installation of Clever Buoy systems at a further six beaches along their coastline.

This pilot installation will act as a precursor to a US$10 million shark management proposal.

Rohrabacher said: “It’s clear that increasing numbers of sharks have been sighted in local waters here in Southern California. In fact, there have been several recent attacks, including a nearly fatal one here at Big Corona Del Mar. This technology can help us save lives and give people confidence in our local beaches.”

Clever Buoy is a non-invasive, early warning shark detection system which identifies shark activity and communicates this information to the appropriate authorities.

Formal support by US federal government representatives, as well as the sheer scale of the US market itself, serves as strong endorsement of SM8’s technology.

Although it is an early stage stock and investors should seek professional financial advice if considering this stock for their portfolio.

SM8 founding director, Craig Anderson, said: “Our shark-detecting sonar technology provides a solution for more than 3,300 patrolled beaches in the US. We are delighted about the opportunity to roll-out our technology in Southern California and encouraged by the US government’s willingness to proactively implement non-invasive methods to protect beach goers.”

According to Rohrabacher, the initial deployment will be underpinned by a federal, state and county funding collaboration, with plans for discussing participation in this initiative with local businesses and residents.

SM8 is committed to focusing on Clever Buoy deployments in California to ensure the project’s success. Subject to finalising funding arrangements and environmental permits in California, the proposed pilot project will use Clever Buoy to assist lifeguards and beach authorities in mitigating the risk of shark attacks along their coastline.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free